Advanced Oncotherapy PLC (LSE:AVO) - Share price - Overview

Stock Report

Advanced Oncotherapy PLC AVO

Last Price
GBX57.50

Day Change
0.00|0.00%

As of 24/02/2017
17:10:34 GMT | GBX
Minimum 15 Minutes Delay.

Last Close57.50p
Day Range56.30 - 59.00
Mkt Cap41.68Mil
52-Wk Range47.00 - 209.88
Yield %0.00
ISINGB00BD6SX109
Volume78,750
P/E-6.35
P/SInfinity
P/CF-3.04

Share Price

Total Returns 24/02/2017

 Chg (%)  
More ...
Advanced Oncotherapy PLC-5.74 
FTSE 100 TR GBP2.08
 
Financials
201320142015
More ...
Income Statement
Turnover0.070.000.00
Operating Profit-3.17-5.84-8.51
Net Profit-3.43-5.70-5.85
Reported EPS-21.50-16.75-11.50
Balance Sheet
Current Assets1.383.1716.68
Non Current Assets10.9111.3014.06
Total Assets12.3014.4730.74
Current Liabilities5.393.343.46
Total Liabilities5.393.343.46
Total Equity6.9111.1327.28
Cash Flow
Operating Cash Flow-2.33-4.65-12.32
Net Change in Cash0.091.327.49
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016--8.90--6.46---
2017--2.60--22.12---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
03/01/2017PurchaseDr Enrico Vanni87.0025,00021,750.00
22/12/2016PurchaseDr Enrico Vanni59.7525,00014,938.00
20/12/2016PurchaseDr Enrico Vanni56.0025,00014,000.00
28/11/2016PurchaseDr Enrico Vanni64.7075,00048,525.00

Company Profile

Advanced Oncotherapy PLC is engaged in providing radiotherapy systems for cancer treatment through the use of a novel proton therapy technology.

Sector

Medical Devices

Market Position

1157 of 1853 Companies

Index

FTSE AIM All Share

Outlook

(30/09/2016) "The company remains optimistic for the future"

Next Event 31/05/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)-22.1217.8116.13
Div Yld (E)0.001.934.10
PEG (E)0.000.821.08
ROCE-46.5035.32104.73
Op Mrgn0.00-15.00-16.30
EPS Grwth0.0036.1235.18
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Michael Sinclair
Chief Executive OfficerNicolas Serandour
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.